Outcomes of study and control patients
| Variables . | Study . | Control . | P . |
|---|---|---|---|
| No. patients | 24 | 48 | |
| Prior chemotherapy cycles | 5.7 (2.9) | 4.0 (2.1) | .010 |
| CD34+ cells infused | 8.4 (5.3) | 11.2 (7.9) | .010 |
| Days to ANC > 500/μL | 7.3 (1.4) | 8.8 (0.7) | .0001 |
| Days to platelet recovery | 9.3 (1.2) | 10.3 (1.6) | .010 |
| Platelet units transfused | 2.7 (2.1) | 2.8 (1.6) | .25 |
| Red cell units transfused | 3.5 (2.0) | 4.2 (1.4) | .02 |
| Days of hospitalization | 15.4 (2.6) | 16.9 (2.1) | .0005 |
| Variables . | Study . | Control . | P . |
|---|---|---|---|
| No. patients | 24 | 48 | |
| Prior chemotherapy cycles | 5.7 (2.9) | 4.0 (2.1) | .010 |
| CD34+ cells infused | 8.4 (5.3) | 11.2 (7.9) | .010 |
| Days to ANC > 500/μL | 7.3 (1.4) | 8.8 (0.7) | .0001 |
| Days to platelet recovery | 9.3 (1.2) | 10.3 (1.6) | .010 |
| Platelet units transfused | 2.7 (2.1) | 2.8 (1.6) | .25 |
| Red cell units transfused | 3.5 (2.0) | 4.2 (1.4) | .02 |
| Days of hospitalization | 15.4 (2.6) | 16.9 (2.1) | .0005 |
Values are mean (± SD).
Probability determined by the Wilcoxon rank sum test.
ANC, absolute neutrophil count.